15th October 2019 – Global Aptamers
Market is anticipated to reach USD 8.91 billion by 2025. Aptamers
implies peptide or oligonucleotides molecules that bind to target protein,
nucleic acid, lipid molecules with a high specificity. Rapidly generated
Aptamers are applied for specific detection, characterization, and inhibition
of proteins. They have several characteristics and could be used as
pharmaceutical leads, detection reagents, small molecules, efficient proteomic
stages with antibodies, and the other aptamers.
The factors that propel the growth of
the aptamers industry include strong trend of R&D savings in pharmaceutical
and biotechnology industries, technological advancements, patent expiration of
systematic development of ligands by exponential improvement technology
(SELEX), and the low price and high productivity of aptamers in binding to
large molecules as related to antibodies. On the other hand, there are factors
that may hamper the growth of the market including low awareness of technology,
and low-income countries. Aptamers Market is anticipated to grow at a
significant CAGR of 28.2% in the upcoming period as the scope, product types,
and its applications are increasing across the globe.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/aptamers-market/request-sample
Aptamers industry may be explored by
type, technology, application, end user, and geography. The market may be
explored by type as XNA-Based Aptamers, and DNA-Based Aptamers, RNA-Based
Aptamers. The “DNA-based Aptamers” segment led the market in 2016 and is
anticipated to maintain its dominance by 2025; even though XNA-based aptamers
will increase at the highest CAGR between 2015 and 2025 owing to increase in demand
for nucleic acid-based diagnostic therapeutics and kits across the globe.
The key applications that could be
explored in the aptamers market include Research and Development, Therapeutics
Development, Diagnostics, and Other Applications. The “Diagnostics” segment led
the market in 2016 and is anticipated to maintain its dominance by 2025 owing
to introduction of novel diagnostic kits by major companies.
The aptamers industry could be explored
based on end user as Contract Research Organizations, Biotechnology and
Pharmaceutical Companies, Academic and Government Research Institutes, and
Other End Users. The “Academic And Government Research Institutes” segment led
the market in 2016 and is anticipated to maintain its dominance by 2025
followed by Biotechnology and Pharmaceutical Companies segment. The industry
may be analyzed by technology as SELEX, and Other Technologies. The “Other
Technologies” segment led the market in 2015 and is anticipated to maintain its
dominance by 2025.
North America accounted for the major
share of the aptamers market size in 2016 and will continue to lead in the
forecast period. The factors that could be attributed to the growth include
increasing number of companies coupled with increasing R&D activities in
this area, and continuous technological advancements in technologies, growing
number of research laboratories and promising government initiatives.
Some of the key players that fuel the
growth of the aptamers industry comprise Aptamer Group, Somalogic Inc., Aptamer
Sciences Inc., Aptagen LLC, Noxxon Pharma, Base Pair Biotechnologies Inc.,
Vivonics Inc, etc. The leading companies are taking up partnerships, mergers
and acquisitions, and joint ventures in order to boost the inorganic growth of
the industry.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment